Oxybutynin and Harvoni drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oxybutynin (oxybutynin) and Harvoni (ledipasvir; sofosbuvir). Common drug interactions include blood urine present among females and cough among males.

The phase IV clinical study analyzes what interactions people have when they take Oxybutynin and Harvoni. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Oxybutynin?

Oxybutynin has active ingredients of oxybutynin. It is often used in urge incontinence. eHealthMe is studying from 23,143 Oxybutynin users. Check the latest studies of Oxybutynin.

What is Harvoni?

Harvoni has active ingredients of ledipasvir; sofosbuvir. eHealthMe is studying from 19,858 Harvoni users. Check the latest studies of Harvoni.

On Jul, 17, 2026

11 people who take Oxybutynin and Harvoni together, and have interactions are studied.

Oxybutynin and Harvoni drug interactions.

What are the common drug interactions of Oxybutynin and Harvoni, by gender? *:

female:

Blood urine present
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Weight increased
Ammonia increased
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Drug ineffective
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Oesophagitis (inflammation of oesophagus)
Sepsis (a severe blood infection that can lead to organ failure and death)

male:

Cough
Drug resistance (reduction in effectiveness of a drug)
Death
Depressed mood
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Electrocardiogram st segment depression
Electrocardiogram t wave inversion
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Tricuspid valve incompetence (inefficient heart valve)
Urinary tract infection

What are the common drug interactions of Oxybutynin and Harvoni, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Depressed mood

40-49:

Blood urine present
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Weight increased

50-59:

Urinary tract infection
Ammonia increased
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Drug ineffective
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Sepsis (a severe blood infection that can lead to organ failure and death)
Unresponsive to stimuli

60+:

Death
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Oesophagitis (inflammation of oesophagus)

What are the existing conditions these people have? *

Hepatitis C: 7 people, 63.64%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 18.18%
Oesophagitis (inflammation of oesophagus): 1 person, 9.09%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 1 person, 9.09%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 1 person, 9.09%
Chronic Hepatitis (long lasting inflammation of liver): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Oxybutynin and Harvoni?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously